Stocks Health care AVIR
NASDAQ · Health careAtea Pharmaceuticals, Inc. (AVIR)
It posted a net loss of $165.3M. At June 30, 2026 it held $76.5M in cash. Its latest periodic report to the SEC is the quarterly report (10-Q) filed on August 12, 2026.
What Atea Pharmaceuticals, Inc. does
Atea Pharmaceuticals, Inc. is registered with the SEC under industry code SIC 2834 (Pharmaceutical Preparations). Its shares trade on NASDAQ under the ticker AVIR.
Revenue and profit by year
Key figures
| Fiscal year | Revenue | Net income | Diluted EPS | Free cash flow |
|---|---|---|---|---|
| 2025 | n/a | -$158.3M | -$1.94 | n/a |
| 2024 | n/a | -$168.4M | -$2.00 | n/a |
| 2023 | n/a | -$136M | -$1.63 | n/a |
| 2022 | n/a | -$115.9M | -$1.39 | -$122.9M |
| 2021 | $351.4M | $121.2M | $1.37 | -$87M |
| 2020 | $48.6M | -$10.9M | -$0.51 | $296.7M |
Latest SEC filings
What Atea Pharmaceuticals, Inc. has filed recently, newest first. Each links to the original document on SEC EDGAR.
- August 12, 2026Quarterly report 10-Q · period to June 30, 2026
- August 12, 2026
- June 22, 2026
- May 12, 2026Quarterly report 10-Q · period to March 31, 2026
- May 12, 2026
- May 6, 2026Passive stake changed SCHEDULE 13G/A
- April 27, 2026Additional proxy material DEFA14A
- April 27, 2026Proxy statement DEF 14A
- March 26, 2026Passive stake changed SCHEDULE 13G/A
- March 5, 2026Annual report 10-K · period to December 31, 2025
Questions about AVIR
What does Atea Pharmaceuticals, Inc. do?
Atea Pharmaceuticals, Inc. is registered with the SEC under industry code SIC 2834 (Pharmaceutical Preparations). Its shares trade on NASDAQ under the ticker AVIR.
Is Atea Pharmaceuticals, Inc. profitable?
No. Over the twelve months to June 30, 2026 it reported a net loss of $165.3M.
When did Atea Pharmaceuticals, Inc. last report?
Its most recent periodic report is the quarterly report (10-Q) filed on August 12, 2026. It covers the period to June 30, 2026.
Similar companies
Follow AVIR
Get an email when Atea Pharmaceuticals, Inc. files with the SEC: results, executive changes, material agreements and annual reports.
Follow AVIR: get an email when it filesWhere the numbers come from
Financial figures are the values Atea Pharmaceuticals, Inc. tagged in its own SEC filings (XBRL), taken from the latest filing for each period, so restatements replace older figures. Revenue, profit and cash flow are for full fiscal years unless marked as the last twelve months, which is the sum of the four most recent quarters. Where a company reports only the full year, the fourth quarter is the year minus the first three.
Prices are delayed end-of-day market data in the listing currency, and market cap moves with the price. P/E is shown only when earnings per share are positive. Nothing here is investment advice.